| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |